Hershman DL, Chen BE, Sathe C, Parulekar WR, et al. Metformin, placebo, and endocrine therapy discontinuation among participants in a randomized double-blind trial of metformin vs placebo in hormone receptor-positive early-stage breast cancer (CCTG MA32). Breast Cancer Res Treat 2023 May 9. doi: 10.1007/s10549-023-06922.
PMID: 37157006